Measurement properties of the Rajka–Langeland severity score in children and adults with atopic dermatitis *

Multiple atopic dermatitis (AD) severity scales exist, with no gold standard for use in clinical practice.

[1]  J. Silverberg,et al.  Development, validation and interpretation of the PROMIS Itch Questionnaire: a patient-reported outcome measure for the quality of life impact of itch. , 2020, Journal of Investigative Dermatology.

[2]  D. Margolis,et al.  A comparison of five ways to measure atopic dermatitis severity in adults , 2020 .

[3]  J. Silverberg,et al.  Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire® (PIQ) Item Banks in adults with atopic dermatitis. , 2019, Journal of the American Academy of Dermatology.

[4]  D. Margolis,et al.  Pain is a common and burdensome symptom of atopic dermatitis in United States adults. , 2019, The journal of allergy and clinical immunology. In practice.

[5]  D. Margolis,et al.  Validation and interpretation of short form 12 and comparison with dermatology life quality index in atopic dermatitis in adults. , 2019, The Journal of investigative dermatology.

[6]  J. Silverberg,et al.  Depression and psychological distress in US adults with atopic dermatitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  J. Silverberg,et al.  The prevalence and persistence of atopic dermatitis in urban United States children. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  D. Margolis,et al.  Validation of five patient‐reported outcomes for atopic dermatitis severity in adults , 2019, The British journal of dermatology.

[9]  D. Margolis,et al.  Distribution of atopic dermatitis lesions in United States adults , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  D. Margolis,et al.  Health Utility Scores of Atopic Dermatitis in US Adults. , 2019, The journal of allergy and clinical immunology. In practice.

[11]  D. Margolis,et al.  Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults , 2019, The British journal of dermatology.

[12]  D. Margolis,et al.  Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. , 2019, The Journal of investigative dermatology.

[13]  J. Silverberg,et al.  A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. , 2019, Journal of the American Academy of Dermatology.

[14]  J. Silverberg,et al.  Measurement properties of three assessments of burden used in atopic dermatitis in adults , 2018, The British journal of dermatology.

[15]  D. Margolis,et al.  Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  J. Silverberg,et al.  Patient-reported outcomes and quality of life measures in atopic dermatitis. , 2018, Clinics in dermatology.

[17]  J. Silverberg,et al.  Sleep Disturbance and Sleep-Related Impairment in Adults With Atopic Dermatitis: A Cross-sectional. , 2018, Dermatitis : contact, atopic, occupational, drug.

[18]  J. Silverberg,et al.  Assessing the severity of atopic dermatitis in clinical trials and practice. , 2018, Clinics in dermatology.

[19]  D. Margolis,et al.  Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  J. Silverberg,et al.  Severity strata for five patient‐reported outcomes in adults with atopic dermatitis , 2018, The British journal of dermatology.

[21]  J. Silverberg,et al.  Validation of patient‐reported global severity of atopic dermatitis in adults , 2018, Allergy.

[22]  J. Silverberg,et al.  Relationship between EASI and SCORAD severity assessments for atopic dermatitis. , 2017, Journal of Allergy and Clinical Immunology.

[23]  J. Silverberg,et al.  Burden of skin pain in atopic dermatitis. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  J. Silverberg,et al.  Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis , 2017, The British journal of dermatology.

[25]  J. Silverberg.  Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders. , 2017, Clinics in dermatology.

[26]  A. Reich,et al.  Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA , 2017, Dermatology.

[27]  H. Williams,et al.  Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement , 2017, The British journal of dermatology.

[28]  C. Terwee,et al.  Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review , 2017, Allergy.

[29]  J. Silverberg,et al.  Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. , 2016, Journal of the American Academy of Dermatology.

[30]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[31]  Å. Svensson,et al.  Usefulness of Rajka & Langeland Eczema Severity Score in Clinical Practice. , 2016, Acta dermato-venereologica.

[32]  J. Silverberg,et al.  Burden of Sleep and Fatigue in US Adults With Atopic Dermatitis , 2016, Dermatitis : contact, atopic, occupational, drug.

[33]  T. Bieber,et al.  Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. , 2016, Journal of the American Academy of Dermatology.

[34]  J. Silverberg,et al.  Association between Atopic Dermatitis and Depression in US Adults. , 2015, The Journal of investigative dermatology.

[35]  J. Silverberg,et al.  Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. , 2015, The Journal of allergy and clinical immunology.

[36]  D. Murrell,et al.  A pilot comparison study of four clinician‐rated atopic dermatitis severity scales , 2015, The British journal of dermatology.

[37]  R. Fitzpatrick,et al.  Floor and ceiling effects in the OHS: an analysis of the NHS PROMs data set , 2015, BMJ Open.

[38]  J. Silverberg,et al.  Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[39]  J. Schmitt,et al.  EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference , 2012, Allergy.

[40]  C. Terwee,et al.  Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist , 2011, Quality of Life Research.

[41]  Alexandru D. P. Papoiu,et al.  Itch characteristics in atopic dermatitis: results of a web‐based questionnaire , 2009, The British journal of dermatology.

[42]  A. Finlay,et al.  The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results , 2008, The British journal of dermatology.

[43]  C. Main,et al.  Illness perception in individuals with atopic dermatitis , 2007, Psychology, health & medicine.

[44]  David J. Hand,et al.  A Simple Generalisation of the Area Under the ROC Curve for Multiple Class Classification Problems , 2001, Machine Learning.

[45]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.

[46]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[47]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[48]  J. Silverberg,et al.  Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. , 2015, The Journal of investigative dermatology.

[49]  C. Terwee,et al.  Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.

[50]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. , 2001, Experimental dermatology.

[51]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[52]  A. Taïeb,et al.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. , 1993, Dermatology.

[53]  G. Rajka,et al.  Grading of the severity of atopic dermatitis. , 1989, Acta dermato-venereologica. Supplementum.